Wirecard AG:企業の戦略・SWOT・財務分析

◆英語タイトル:Wirecard AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5245
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥55,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Wirecard AG – Strategy, SWOT and Corporate Finance Report
Summary

Wirecard AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Wirecard AG (Wirecard) is a provider of electronic payment solutions. It offers payment processing, risk management, and other value-added services. The company provides settlement services to retailers for online and terminal payments executed through credit cards and allows them to process the transactions in various currencies. It issues debit and prepaid cards to individuals and business customers. The company also offers current accounts in combination with prepaid and EC/Maestro cards to individual clients. Wirecard is a partner to many global credit cards companies such as Visa, MasterCard, UnionPay, Amex, DinersClub, JCB, and Discover International. It has presence in Europe, Asia-Pacific, Americas and Africa. Wirecard is headquartered in Aschheim, Germany.

Scope

- Detailed information on Wirecard AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Wirecard AG in the form of a SWOT analysis
- An in-depth view of the business model of Wirecard AG including a breakdown and examination of key business segments
- Intelligence on Wirecard AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Wirecard AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Wirecard AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Wirecard AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Wirecard AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Wirecard AG: Company Overview
Wirecard AG: Overview and Key Facts
Wirecard AG: Overview
Wirecard AG: Key Facts
Wirecard AG: Key Employees
Wirecard AG: Key Employee Biographies
Wirecard AG: Major Products and Services
Wirecard AG: Company History
Wirecard AG: Management Statement
Wirecard AG: Locations and Subsidiaries
Wirecard AG: Key Competitors
Wirecard AG: Company Analysis
Wirecard AG: Business Description
Wirecard AG: SWOT Analysis
Wirecard AG: SWOT Overview
Wirecard AG: Strengths
Wirecard AG: Weaknesses
Wirecard AG: Opportunities
Wirecard AG: Threats
Wirecard AG: Corporate Financial Deals Activity
Wirecard AG: Financial Deals Overview
Wirecard AG: Targets and Partners
Wirecard AG: Top Deals 2016 – 2020YTD*
Wirecard AG: Advisors
Wirecard AG: Top Legal Advisors
Wirecard AG: Top Financial Advisors
Wirecard AG: Mergers and Acquisitions
Wirecard AG: Capital Raising
Wirecard AG: Partnership
Wirecard AG: Recent Developments
Wirecard AG: News and Events Summary
Wirecard AG: Business Expansion
Wirecard AG: Contracts
Wirecard AG: IT Spending Announcements
Wirecard AG: Market Developments
Wirecard AG: Regulatory and Legal Events
Wirecard AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Wirecard AG: Key Facts
Table 2: Wirecard AG: Key Employees
Table 3: Wirecard AG: Company History
Table 4: Wirecard AG: Locations and Subsidiaries
Table 5: Wirecard AG: Key Competitors
Table 6: Wirecard AG: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Wirecard AG: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Wirecard AG: M&A Average Deal Size - Value (US$m)
Table 9: Wirecard AG: Targets and Partners
Table 10: Wirecard AG: Top Deals 2016 - 2020YTD*
Table 11: Wirecard AG: Legal Advisor Ranking by Value (US$m)
Table 12: Wirecard AG: Financial Advisor Ranking by Value (US$m)
Table 13: Wirecard AG: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Wirecard AG: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Wirecard AG: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 16: Wirecard AG: Capital Raising by Deal Type (2016 - YTD*2020)
Table 17: Wirecard AG: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 18: Wirecard AG: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 19: Wirecard AG: News and Events Summary
Table 20: Wirecard AG: Business Expansion
Table 21: Wirecard AG: Contracts
Table 22: Wirecard AG: IT Spending Announcements
Table 23: Wirecard AG: Market Developments
Table 24: Wirecard AG: Regulatory and Legal Events
Table 25: Wirecard AG: Strategy and Operations

★海外企業調査レポート[Wirecard AG:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Penumbra Inc (PEN):医療機器:M&Aディール及び事業提携情報
    Summary Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures and markets neuro devices and peripheral devices. The company’s neurovascular mechanical thrombectomy systems include revascularization device, reperfusion catheters, distal delivery catheters, neuro eva …
  • Dentsu Inc. (4324):企業の財務・戦略的SWOT分析
    Dentsu Inc. (4324) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Merck & Co Inc (MRK)-製薬・医療分野:企業M&A・提携分析
    Summary Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products. It offers prescription products for treating cardiovascular, cancer, immunology, infectious, respirato …
  • Garvan Institute of Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Garvan Institute of Medical Research (Garvan Institute) is a biomedical institute that offers research services. The institute conducts research in the fields of cancer, diabetes and obesity, Alzheimer’s and Parkinson’s disease, asthma, rheumatoid arthritis, osteoporosis, arthritis and pitui …
  • Showa Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Memphasys Ltd (MEM)-製薬・医療分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a life science company that develops and sells pre-cast electrophoresis gels, separations equipment and consumables, analytical software, and other biological products. The company offers gels which include tris glycine, and tris hepe …
  • RhythmOne plc:企業のM&A・事業提携・投資動向
    RhythmOne plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RhythmOne plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Novartis AG (NOVN):医療機器:M&Aディール及び事業提携情報
    Summary Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, n …
  • Momenta Pharmaceuticals Inc (MNTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s products include Glatopa; and Enoxaparin Sodium Injection. Its pipeline portfolio encompasses candidates to su …
  • KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xue …
  • Lafarge Malaysia Berhad (LAFMSIA):企業の財務・戦略的SWOT分析
    Summary Lafarge Malaysia Berhad (LMB), formerly Lafarge Malayan Cement Berhad is a construction company that manufactures and markets aggregates, ready-mixed concrete, cement, and related construction and building materials. The company offers cement products such as walcrete, rumah, phoenix, oil we …
  • AMCON Distributing Company:戦略・SWOT・企業財務分析
    AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report Summary AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • A2B Australia Limited
    A2B Australia Limited - Strategy, SWOT and Corporate Finance Report Summary A2B Australia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Covestro AG (1COV):企業の財務・戦略的SWOT分析
    Covestro AG (1COV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Inditex SA (ITX):企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Investment Technology Group, Inc.:企業の戦略・SWOT・財務分析
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆